New estimates of the indispensable amino acid requirements of adult humans are much higher than previously thought and questions the adequacy of cereal-based diets of low protein quality. However, dietary amino acid requirements may be supplemented by contributions from the intestinal microbiota. This study measured the contribution of intestinal microbes to leucine input in healthy adult men. Fourteen adult men were studied during each of 2 11-d periods (before and after intestinal antimicrobial treatment), in which leucine was supplied at 1.25 times the estimated average requirement (EAR) (d 1-7) and at 2.5 times the EAR (d 8-11) providing an L-amino acid diet. We estimated fasting-and fed-state leucine oxidation on d 7 and d 11 using a 13 C-leucine tracer infusion. The microbial contribution to body leucine input was calculated from the relationship of leucine oxidation to leucine intake and the reduction in leucine oxidation after antimicrobial treatment. Antimicrobial treatment did not affect the slope of the relationship of leucine oxidation to leucine intake. Mean and fed-state leucine oxidation declined by ;13 and 20%, respectively (both P , 0.05) after antimicrobial treatment with the 1.25 EAR diet, but not with the 2.5 EAR diet. The contribution of the intestinal microbiota to body leucine input was estimated to be between 19 and 22% at the 1.25 EAR diet. The contribution of the intestinal microbiota to body amino acid homeostasis may be significant at maintenance intakes, but its long-term nutritional importance remains to be determined.
Introduction
The recent WHO/FAO/UNU recommendations for the daily requirement of indispensable amino acids in adults (1) are ;2-to 3-fold of the earlier recommendations (2) . These new estimates mean that in disadvantaged populations, the intakes of limiting amino acids are likely to be marginally deficient. In a calculation of the risk of dietary protein deficiency, based on a protein:energy ratio adjusted for protein quality, it was estimated that, based on their habitual intakes, 23% of the sedentary adult male population of India could be at risk of amino acid deficiency (3) . The deficiency could actually be greater, because the daily lysine requirement of chronically undernourished Indian men was found to be ;50% higher than that of their well-nourished counterparts (4) and a significant proportion of this increase could be attributed to environmental effects such as intestinal parasitic infestation (5) .
It is conventionally assumed that all the essential amino acid requirements of humans (and other nonruminants) must be supplied by the diet. However, there is evidence of substantial absorption of essential amino acids synthesized by the gut microbiota in simple-stomached animals and humans (6, 7) . From labeling experiments using 15 NH 4 Cl incorporation into microbial lysine in normal human subjects and ileostomates, it has been estimated that microbial lysine absorption was 29-68 mgÁkg 21 . d 21 , which is of the same order as the estimated average requirement (EAR) 5 of lysine (30 mgÁkg 21. d 21 ) in human adults (8) . However, although this suggests that nutritionally relevant amounts of microbially derived lysine are absorbed, quantifying the amount absorbed is technically complicated by the need to estimate the 15 N enrichment of the lysine being absorbed, which seems to occur mostly in the small intestine (9, 10) . In normal humans, estimates of microbial lysine absorption based on the 15 N-lysine enrichments of fecal microbes are almost certainly incorrect, because there is continued incorporation of 15 N from ammonia into microbial amino acids in the colon, from which there is little absorption (9, 10) . Estimates based on the 15 N-lysine enrichments of microbes in ileostomy effluent is also unlikely to be correct, because a consequence of ileostomy is an increase in microbial numbers and an alteration of the constituent species of the ileal microflora (11) . These uncertainties make the interpretation of such 15 Nlabeling studies difficult. Nevertheless, the fact that there is some, albeit poorly quantified, absorption of microbially syn-thesized amino acids leads to the concept of a metabolic amino acid supply, which is the sum of the dietary supply and the contribution of the intestinal microbiota.
Because the amounts of amino acids supplied by the intestinal microbial route have not been satisfactorily quantified, we devised a method based on the linear relationship between leucine oxidation and leucine intake at intakes that are well above the daily leucine requirement level of 40 mgÁkg 21 . d 21 (12) . If the total metabolic leucine input into the body is considered as the sum of dietary and microbially derived leucine, then by reducing the numbers of intestinal microbes, the leucine input into the body would be expected to decrease. This decline in leucine oxidation would then allow the microbially derived leucine supply to be estimated from the slope of the relationship between leucine intake and oxidation. The calculation of microbially derived leucine input would also allow estimation, based on the amino acid composition of microbial proteins, of the input of other indispensable amino acids by this route. This study was therefore designed to quantify the microbially derived leucine input in healthy South Indian men.
Subjects and Methods
Fourteen otherwise healthy adult male subjects in a normal BMI range participated in this experiment. Subjects were screened using a medical history, physical examination, blood cell count, and a routine biochemical profile that included fasting blood sugar, liver function tests, and serum urea and creatinine. The subjects were weighed to the nearest 0.1 kg and their height was measured to the nearest 1.0 cm. The logarithm of the sum of 4 (biceps, triceps, subscapular, and suprailiac) skinfolds was used in age-and gender-specific equations (13) to obtain an estimate of body density, from which body fat and fat-free mass were estimated (14) ( Table 1 ). The purpose of the study and the potential risks involved were explained to each subject and a written informed consent was obtained from each subject. The Institutional Ethical Review Board of St. John's Medical College approved the research protocol.
The subjects were studied during 2 11-d periods in a metabolic ward, first without and then with antibiotics. The subjects were given daily energy intakes that were designed to maintain body weight; the subjects were also encouraged to maintain their customary levels of physical activity based on an activity schedule. Dietary energy was supplied as flavored drinks and protein-free, wheat starch cookies, and all other nutrients provided in adequate amounts as described earlier (15) . Their amino acid intake was provided by an L-amino acid mixture ( During the first 11-d period, the subjects underwent a 3-d dietary adaptation in which the basal diet was provided as 3 meals/d (d 1-3) with leucine provided at 1.25 times the EAR (1). Subsequently, for the next 4 d (d 4-7), the subjects were provided the same diet but as small isoenergetic hourly meals over 12 h, because this mimicked the pattern of feeding during the tracer experiment. On d 7, leucine oxidation was determined during the last 120 min of the fasting period and during the last 90 min of the feeding period. Following this experimental protocol for the next 4 d, each subject was provided the same diet with added leucine (2.5 times EAR) in the same feeding pattern of hourly meals. Leucine oxidation was measured as before, on d 11. The diet periods were separated by 2 to 4 wk, and during this interval, subjects consumed their free-choice diets. During the 2nd 11-d diet period, the subjects received an antibiotic and antifungal treatment regimen that consisted of ciprofloxacin (500 mg, Cipla) and fluconazole (200 mg, Cipla) twice daily. On the same dose of ciprofloxacin, .99% of Bacteroides, Escherichia coli, Streptococcus fecalis, Clostridium spp., and Candida were eliminated after 2 d (16).
The primed i.v.
13
C-leucine approach was used, with indirect calorimetry, blood, and breath sampling as previously described (15) . The total duration of the tracer infusion was 18 h, which began at 0000 and ended at 1800. Briefly, 1- h 21 (the prime was ;4.2 mmol/kg). The bicarbonate pool was primed with 0.8 mmol/kg of 13 C-sodium bicarbonate (99 atom%; MassTrace). Baseline blood and breath samples were collected at 230, 215, and 25 min before the infusion began. Blood and breath samples were collected every 30 min during the last 120 min of the fasting period (0400-0600) and similarly collected every 30 min during the last 90 min of the fed period (1630-1800). The analyses of breath for 13 CO 2 enrichment by isotope ratio MS (Europa Scientific) and plasma samples for 13 C-a-ketoisocaproic acid (KIC) by GC-MS (Varian) were as previously described (15 ) to plasma 13 C-KIC enrichment (mole percent excess) ratio, whereas the leucine flux was calculated as the ratio of the ) to the plasma 13 C-KIC enrichment (mole percent excess).
The anthropometric and metabolic variables are presented as arithmetic means 6 SD. The study was powered to look for 1-tailed significant differences in leucine oxidation between the 2 phases of the study (because it was expected that no increase in leucine oxidation would occur after antimicrobial therapy) for either leucine intake, assuming a 20% difference between phases, SD that was 25% of the mean, power of 80%, and a 5% level of significance. Therefore, the primary analysis for differences in leucine oxidation between the 2 phases of the study, the 2 leucine intakes, and between metabolic periods (fasting and fed) were the 1-tailed Student's paired t test, because leucine oxidation was expected to increase only with feeding or with increased dietary intake. The data were also subjected to secondary analysis using a 3-level model in which each subject was measured in 2 phases, with 2 leucine intakes and 2 metabolic phases as within-phase variables. We used a pooled regression of leucine oxidation on leucine intake to test for significant differences in slopes between the phases of the study. The slope of the leucine oxidation-leucine intake relationship in the pretreatment phase was used along with the difference in the oxidation of leucine between the pre-and post-treatment phases to calculate the reduction in leucine input into the body when antimicrobials were given. Results were considered significant if P # 0.05. The data were analyzed using SPSS (v13.0).
Results
The mean BMI was ;21 kg/m 2 and the mean percent body fat in the subjects was ;17% (Table 1 ). The subjects' blood biochemical parameters were within normal limits at recruitment. Their mean erythrocyte sedimentation rate (ESR) was 5.9 6 4.0 mm/h . Body weight of the subjects did not differ between the phases of the study. There were no adverse side effects from the antibiotic treatment and none of the subjects reported any symptoms or change in appetite or bowel movements.
Based on the primary analysis (Table 3) , the fasting-and fedstate leucine oxidation rates in either the pre-or post-treatment phases did not change after the 1.25 EAR leucine diet was fed; however, these differences were significant after the 2.5 EAR diet was fed (P , 0.001 for both pre-and post-treatment phases). The fed-state leucine oxidation rate was greater with the 2.5 EAR than with the 1.25 EAR leucine diet (P , 0.001, for both treatment phases). With the 1.25 EAR diet, the fed-state leucine oxidation rate was lower after giving antibiotics (P ¼ 0.02). When the entire data set was analyzed by a 3-level model, there was a significant effect of treatment phase within leucine intakes and metabolic phases (P , 0.001). Post-hoc analysis revealed that the 1-tailed significant difference between treatment phases lay in the fed-state oxidation at the 1.25 EAR leucine intake level, as shown in the primary analysis.
Because the nutritionally relevant microbial contribution of leucine should be calculated for the whole day (see below), the mean of the fasting-and fed-state leucine oxidation rate was analyzed for differences between treatment phases. There was a similar difference between the phases of treatment in mean leucine oxidation rate when the 1.25 EAR diet was fed (P ¼ 0.05), but not when the 2.5 EAR diet was fed. There were no changes in leucine flux or in nonoxidative leucine disposal between treatment phases, diets, or metabolic states by either the primary or secondary analysis.
The decline in the mean value of the fasting-and fed-state leucine oxidation rates, with the 1.25 EAR diet, was used to assess the microbial contribution to daily body leucine supply. The slope of the leucine oxidation-leucine intake relation did not differ between the pre-and post-treatment phases ( ), was used to estimate the decrease in leucine input into the body due to antibiotic treatment. These calculations were not made with the 2.5 EAR diet, because there was an effect of treatment phase within leucine intakes (1.25 or 2.5 EAR) and metabolic phase (P , 0.001) and because, at that intake, antibiotics did not reduce the fedstate leucine oxidation rate. The microbially derived leucine input was estimated to be 9.6 mgÁkg 21. d 21 , which represents 19.2% of the leucine intake provided by the 1.25 EAR diet. 
Gut microbial contribution to leucine absorption 2219
When the microbial contribution to leucine input into the body was calculated using the mean of the fasting-and fed-state leucine oxidation data for evaluating a possible whole-day contribution, the corresponding value for the mean slope was 0. 13 
Discussion
Recommendations for the daily requirement for amino acids conventionally assume that all these requirements would come from the diet and that there is no other source of these amino acids. However, microbes within the gastrointestinal tract are capable of hydrolyzing urea and synthesizing essential amino acids. Although the magnitude of the contribution could not earlier be determined with any certainty (8), the present study suggests that the microbial contribution to the supply of leucine was between 19 and 22% of the intake (1.25 EAR), depending on the method of calculation. This corresponds to ;24-27% of the EAR (1). By extension, one would expect the microbial supply of other indispensable amino acids to be a broadly similar proportion of requirements.
In previous studies, based on the administration of 15 N ammonium chloride, the microbial contribution to lysine absorption in normal adults and ileostomates was measured from the 15 N enrichment of lysine in plasma and in the microbial fraction of feces or ileostomy fluid, along with measurements of the plasma rate of appearance of 15 N-lysine (8, 16) . Other studies of fecal microbial and urinary lysine enrichments in adults given lactose-( 15 N) 2 -ureide suggested an availability of microbial lysine that matched the daily requirement (17) , whereas studies on undernourished infants administered 15 N 2 -urea, along with the measurement of urinary lysine enrichment and an assumption of the fecal microbial lysine enrichment, suggested de novo lysine synthesis rates that were ;10% or more of the daily requirement in these children in whom the rate of urea hydrolysis was high (18) . These estimates of the availability of microbially derived lysine were substantial in relation to the dietary requirement, but depend critically on 2 assumptions. The first is that the 15 N enrichment of lysine in the microbial protein that is isolated from digesta is a true measure of the microbial lysine being absorbed. Because there is likely to be continued incorporation of 15 N from ammonia into microbial amino acids in the colon, this value may be very different from that at the sites of absorption, which seem to be mostly in the small intestine (9, 10) . Although the ileostomates had a lower plasma 15 N-lysine enrichment than the intact subjects given the same amount of 15 N ammonium chloride, the 15 N enrichment of lysine in the microbial protein of ileostomy fluid was less than one-third of that in the fecal microbial protein of intact subjects (8, 16) ; as a result, the estimated microbial lysine uptake was 68 mgÁkg 21 . d 21 or more than twice the requirement. Using the urea enrichment as a surrogate for fecal microbial enrichment is also likely to underestimate microbial lysine availability, because other sources of N are available for microbial protein synthesis in the gut (19, 20) . The uncertainties about the actual 15 N enrichment of the lysine being absorbed make the precise interpretation of these 15 N-labeling experiments difficult. In fact, the same problem exists for other tracers, such as 14 C (9). We therefore devised an alternative approach to measure the contribution of indispensable amino acids from the intestinal microflora, based on the linear relationship between the change in leucine intake and the change in oxidation, at leucine intakes that are above the daily requirement (12) . Our reasoning was that if there were an appreciable microbial leucine input into the body, that would be reduced by the suppression of intestinal microbes, leading to a decrease in the metabolic leucine input into the body with a corresponding decrease in leucine oxidation. This decrease in leucine oxidation could then be used to predict the amount of microbially derived leucine from the slope of the previously defined relationship between leucine intake and oxidation. We compared the slopes of this relationship before and after antimicrobial treatment to assess if the treatment had any effect on this relationship. The fact that there was no significant change in pooled slopes suggests that there was no systematic effect of the antibiotics on leucine kinetics.
Previous estimates of the contribution of microbial amino acids to the host's needs (7-10) involve a 2nd assumption: that microbial amino acids are entirely synthesized de novo, using nitrogen that would otherwise be of little or no nutritional value, such as urea or ammonia. Recent studies of pigs (19, 20) given simultaneous infusions of L-[1-
13 C]-valine and [ 15 N 15 N]-urea suggest that only a small proportion of valine in microbial protein is synthesized de novo using N from urea; a larger proportion is preformed valine from endogenous secretions (detected as [1- 13 C]-valine) and the largest proportion, by difference, was assumed to be preformed valine from the diet. Thus, although estimates of microbial lysine absorption may be correct, they do not represent a net gain of amino acid but, to the extent that microbial amino acids from dietary or endogenous sources are incorporated intact into microbial protein that is later digested, they simply describe an additional step in the route by which those amino acids reach the host.
By contrast, the present approach attempts to assess the net benefit to the host, avoiding the assumptions required by previous approaches but requiring its own, different assumptions. Most importantly, it is assumed that the only effect of antibiotic treatment on amino acid metabolism was to suppress the microbial supply. It is possible, however, that the effect of the antimicrobial therapy was 2-fold and that the Indian subjects had subclinical infections that were eliminated by the antibiotic treatment. Minor inflammation can increase leucine oxidation by ;10% (21) and, if present, could have accounted for a substantial portion of the observed reduction in leucine oxidation after antimicrobial treatment. This would mean that the amino acid contribution from intestinal microbes was less than what was observed. However, the ESR and total white blood cell counts of the subjects did not suggest that there was any ongoing infection, although 4 of the subjects had ESR values that were at the upper end of the normal range. On the other hand, the change in microbial amino acid supply may have been underestimated if the gut microbiota were not effectively eliminated. There are differences in the susceptibility to antibiotics of different microbial species and in different geographical regions. Ciprofloxacin has been widely used in India in the recent past and it is possible that varying degrees of antibiotic resistance could be present in different bacteria in the gut, as has been observed for pathogenic bacteria (22) . It is also possible that there could have been an increased intestinal loss of amino acids because of the effect of the antimicrobial therapy on intestinal permeability or absorption. However, intestinal permeability has not been shown to change after antibiotics in elective colorectal surgery patients (23) , nor have any effects on amino acid absorption been reported for quinolones. It has been shown that some antibiotics, such as viriginiamycin, improve intestinal digestibility of proteins in pigs; however, it is difficult to make an unequivocal interpretation of these findings related to the present study (24) . It is also unlikely that the antimicrobial treatment affected body leucine metabolism because the slope of the D oxidation: D intake response was similar before and after treatment.
In conclusion, it appears that the intestinal microbiota make a measurable contribution, of the order of 24-27% of the EAR, to the supply of leucine, and, by extension, of other indispensable amino acids to the body. Such a nutritionally relevant, microbially derived contribution to body amino acid homeostasis might partly explain how undernourished populations, living on cereal-based diets marginal in protein and amino acids, can nevertheless adapt and survive.
